Johnson & Johnson at Sanford C Bernstein Strategic Decisions Conference Transcript
Okay. We are live. Great. Thank you. So hi everybody, I'm Lee Hambright, U.S. medical device analyst at Bernstein. We are thrilled to host Johnson & Johnson, Chairman and CEO, Joaquin Duato. Thanks so much for being here. We're scheduled for a 50-minute fireside chat. Just a reminder that you can submit questions through pigeon hole at any time.
Joaquin, thanks so much for being here. It's been 1.5 years since you stepped into the CEO role. Maybe you could just start by reflecting a little bit on your experiences and talking about the state of the business at J&J.
Thank you, and thank you for coming to listen to this fireside chat. So let's start with the first quarter and see how Johnson & Johnson has been doing. We had a good first quarter with adjusted (added by company after the call) operational growth for Johnson & Johnson of over (added by company after the call) 7.5%, which you have
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
